Investigators evaluated the proportion, clinical characteristics, and survival of patients with lung cancer who met or were excluded from USPSTF criteria and used institutional and published data to ...

Gut dysbiosis caused by gastric acid suppression has been shown to affect the efficacy of immune checkpoint inhibitor treatment in some cancers, but not in HCC.

GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.

The EPCORE FL-1 trial evaluated epcoritamb plus lenalidomide and rituximab versus plus lenalidomide and rituximab for ...

Investigators sought to identify a relationship between cruciferous vegetable intake and breast cancer risk in the Nurses’ Health Study (NHS) and NHSII.

Investigators assessed long-term PFS and safety results for acalabrutinib, bendamustine, and rituximab in the phase 3 ECHO trial.

Patients with extensive-stage SCLC who received immunochemotherapy before 15:00 hrs exhibited significantly longer PFS, overall survival.

Researchers sought to determine whether zanubrutinib plus obinutuzumab would be effective in treating patients with R/R FL.

Experts explore the multifaceted barriers to cryopreserved sperm use and propose specific solutions to help survivors achieve their reproductive goals.

In this study, researchers sought to determine whether Medicaid expansion led to improvements in survival for patients with resectable NSCLC.

In the phase 2 Smart Stop trial, researchers investigated the feasibility of achieving durable complete responses in DLBCL without the use of chemotherapy.

At ASH 2025, researchers reported on 3-year efficacy and safety of lisocabtagene maraleucel in follicular lymphoma patients being treated in the third-line setting or later.